Hospital death | ||||
---|---|---|---|---|
Characteristic | Total n (%) | Yes, n (%) | No, n (%) | p Value |
Gender | ||||
Women | 242 (49.0) | 121 (50.0) | 121 (50.0) | 0.13 |
Men | 252 (51.0) | 144 (57.1) | 108 (42.9) | |
Age group | ||||
28 days–1 year | 152 (30.8) | 99 (65.1) | 53 (34.9) | 0.01 |
1–4 years | 104 (21.1) | 53 (51.0) | 51 (49.0) | |
5–9 years | 57 (11.5) | 25 (43.9) | 32 (56.1) | |
10–14 years | 76 (15.4) | 40 (52.6) | 36 (47.4) | |
15–18 years | 105 (21.3) | 48 (45.7) | 57 (54.3) | |
Socioeconomic status (NZdep2006) | ||||
Quintile 1 (least deprived) | 79 (16.2) | 43 (54.4) | 36 (45.6) | 0.39 |
Quintile 2 | 92 (18.8) | 48 (52.2) | 44 (47.8) | |
Quintile 3 | 73 (14.9) | 32 (43.8) | 41 (56.2) | |
Quintile 4 | 99 (20.2) | 52 (52.5) | 47 (47.5) | |
Quintile 5 (most deprived) | 146 (29.9) | 85 (58.2) | 61 (41.8) | |
Ethnic group | ||||
Asian | 33 (6.7) | 22 (66.7) | 11 (33.3) | 0.02 |
European | 256 (51.8) | 123 (48.0) | 133 (52.0) | |
MELAA | 4 (0.8) | 1 (25.0) | 3 (75.0) | |
Maori | 139 (28.1) | 79 (56.8) | 60 (43.2) | |
Other | 1 (0.2) | 0 | 1 (100) | |
Pacific peoples | 61 (12.3) | 40 (65.6) | 21 (34.4) | |
Diagnostic category | ||||
Malignancy | 145 (29.4) | 54 (37.2) | 91 (62.8) | <0.0001 |
Cardiac | 64 (13.0) | 37 (57.8) | 27 (42.2) | |
Chromosomal/syndrome | 29 (5.9) | 13 (44.8) | 16 (55.2) | |
Gastro/liver | 13 (2.6) | 11 (84.6) | 2 (15.4) | |
Immunology/infection | 11 (2.2) | 8 (72.7) | 3 (27.3) | |
Metabolic | 31 (6.3) | 14 (45.2) | 17 (54.8) | |
Neurology | 137 (27.7) | 78 (56.9) | 59 (43.1) | |
Renal | 7 (1.4) | 4 (57.1) | 3 (42.9) | |
Respiratory | 54 (10.9) | 44 (81.5) | 10 (18.5) | |
Other | 3 (0.6) | 2 (66.7) | 1 (33.3) | |
Total malignancy | 145 (29.4) | 54 (37.2) | 91 (62.8) | <0.0001 |
Total non-malignancy | 349 (70.6) | 211 (60.5) | 138 (39.5) | |
Paediatric palliative care | ||||
Yes | 106 (21.5) | 43 (40.6) | 63 (59.4) | 0.003 |
No | 388 (78.5) | 222 (57.2) | 166 (42.8) |
MELAA, Middle Eastern, Latin American, African.